IART logo

IART Accounts Receivable

Annual Accounts Receivable

$259.33 M
-$4.14 M-1.57%

December 31, 2023


Summary


Performance

IART Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIARTbalance sheetmetrics:

Quarterly Accounts Receivable

$248.30 M
-$22.86 M-8.43%

September 30, 2024


Summary


Performance

IART Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIARTbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

IART Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.6%-3.1%
3 y3 years+15.0%-3.1%
5 y5 years-2.4%-3.1%

IART Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1.6%+11.9%-8.4%+7.1%
5 y5-year-5.8%+15.0%-9.8%+38.6%
alltimeall time-5.8%+1881.6%-16.3%+1863.3%

Integra LifeSciences Holdings Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$248.30 M(-8.4%)
Jun 2024
-
$271.15 M(+12.5%)
Mar 2024
-
$241.09 M(-7.0%)
Dec 2023
$259.33 M(-1.6%)
$259.33 M(+1.2%)
Sep 2023
-
$256.27 M(-0.9%)
Jun 2023
-
$258.66 M(+1.8%)
Mar 2023
-
$254.00 M(-3.6%)
Dec 2022
$263.46 M(+13.6%)
$263.46 M(+6.1%)
Sep 2022
-
$248.27 M(+4.6%)
Jun 2022
-
$237.36 M(+1.4%)
Mar 2022
-
$234.01 M(+0.9%)
Dec 2021
$231.83 M(+2.8%)
$231.83 M(+4.3%)
Sep 2021
-
$222.23 M(-3.3%)
Jun 2021
-
$229.82 M(+2.8%)
Mar 2021
-
$223.54 M(-0.9%)
Dec 2020
$225.53 M(-18.1%)
$225.53 M(+3.4%)
Sep 2020
-
$218.18 M(+21.8%)
Jun 2020
-
$179.14 M(-27.0%)
Mar 2020
-
$245.55 M(-10.8%)
Dec 2019
$275.30 M(+3.6%)
$275.30 M(-2.1%)
Sep 2019
-
$281.12 M(-5.2%)
Jun 2019
-
$296.51 M(+6.2%)
Mar 2019
-
$279.07 M(+5.0%)
Dec 2018
$265.74 M(+5.5%)
$265.74 M(+6.8%)
Sep 2018
-
$248.74 M(-3.7%)
Jun 2018
-
$258.38 M(-5.1%)
Mar 2018
-
$272.26 M(+8.1%)
Dec 2017
$251.80 M(+69.9%)
$251.80 M(+47.1%)
Sep 2017
-
$171.13 M(-0.1%)
Jun 2017
-
$171.32 M(+8.3%)
Mar 2017
-
$158.23 M(+6.8%)
Dec 2016
$148.19 M(+12.1%)
$148.19 M(+5.3%)
Sep 2016
-
$140.75 M(-3.3%)
Jun 2016
-
$145.57 M(-4.0%)
Mar 2016
-
$151.61 M(+14.6%)
Dec 2015
$132.24 M(+19.8%)
$132.24 M(+5.4%)
Sep 2015
-
$125.47 M(-6.7%)
Jun 2015
-
$134.55 M(+6.1%)
Mar 2015
-
$126.78 M(+14.8%)
Dec 2014
$110.41 M(-6.5%)
$110.41 M(-8.6%)
Sep 2014
-
$120.74 M(+2.1%)
Jun 2014
-
$118.26 M(+5.1%)
Mar 2014
-
$112.52 M(-4.8%)
Dec 2013
$118.14 M(+2.8%)
$118.14 M(+4.1%)
Sep 2013
-
$113.54 M(-1.1%)
Jun 2013
-
$114.75 M(+2.5%)
Mar 2013
-
$111.94 M(-2.6%)
Dec 2012
$114.92 M
$114.92 M(-3.9%)
DateAnnualQuarterly
Sep 2012
-
$119.53 M(+3.4%)
Jun 2012
-
$115.57 M(+1.4%)
Mar 2012
-
$114.00 M(-3.5%)
Dec 2011
$118.13 M(+11.4%)
$118.13 M(+0.3%)
Sep 2011
-
$117.78 M(+1.4%)
Jun 2011
-
$116.18 M(+9.5%)
Mar 2011
-
$106.12 M(+0.1%)
Dec 2010
$106.00 M(+2.7%)
$106.00 M(-1.1%)
Sep 2010
-
$107.15 M(+9.6%)
Jun 2010
-
$97.78 M(-0.8%)
Mar 2010
-
$98.53 M(-4.5%)
Dec 2009
$103.23 M(-8.2%)
$103.23 M(+1.8%)
Sep 2009
-
$101.38 M(-0.1%)
Jun 2009
-
$101.46 M(-0.1%)
Mar 2009
-
$101.61 M(-9.6%)
Dec 2008
$112.42 M(+8.6%)
$112.42 M(+1.2%)
Sep 2008
-
$111.08 M(+2.7%)
Jun 2008
-
$108.13 M(+1.2%)
Mar 2008
-
$106.88 M(+3.2%)
Dec 2007
$103.54 M(+21.8%)
$103.54 M(+12.2%)
Sep 2007
-
$92.31 M(-3.1%)
Jun 2007
-
$95.27 M(+10.9%)
Mar 2007
-
$85.88 M(+1.0%)
Dec 2006
$85.02 M(+73.5%)
$85.02 M(+10.8%)
Sep 2006
-
$76.72 M(+3.5%)
Jun 2006
-
$74.14 M(+31.0%)
Mar 2006
-
$56.61 M(+15.5%)
Dec 2005
$49.01 M(+4.8%)
$49.01 M(+4.7%)
Sep 2005
-
$46.79 M(+1.1%)
Jun 2005
-
$46.27 M(-9.7%)
Mar 2005
-
$51.26 M(+9.6%)
Dec 2004
$46.77 M(+61.6%)
$46.77 M(+23.0%)
Sep 2004
-
$38.03 M(+6.7%)
Jun 2004
-
$35.65 M(+17.6%)
Mar 2004
-
$30.32 M(+4.8%)
Dec 2003
$28.94 M(+49.1%)
$28.94 M(+7.3%)
Sep 2003
-
$26.96 M(+13.7%)
Jun 2003
-
$23.72 M(-1.4%)
Mar 2003
-
$24.07 M(+24.0%)
Dec 2002
$19.41 M(+38.4%)
$19.41 M(+9.5%)
Sep 2002
-
$17.72 M(+13.3%)
Jun 2002
-
$15.64 M(+5.5%)
Mar 2002
-
$14.83 M(+5.7%)
Dec 2001
$14.02 M(+7.2%)
$14.02 M(-3.0%)
Sep 2001
-
$14.45 M(-3.8%)
Jun 2001
-
$15.03 M(+18.9%)
Mar 2001
-
$12.65 M(-3.4%)
Dec 2000
$13.09 M
$13.09 M

FAQ

  • What is Integra LifeSciences Holdings annual accounts receivable?
  • What is the all time high annual accounts receivable for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings annual accounts receivable year-on-year change?
  • What is Integra LifeSciences Holdings quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly accounts receivable year-on-year change?

What is Integra LifeSciences Holdings annual accounts receivable?

The current annual accounts receivable of IART is $259.33 M

What is the all time high annual accounts receivable for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high annual accounts receivable is $275.30 M

What is Integra LifeSciences Holdings annual accounts receivable year-on-year change?

Over the past year, IART annual accounts receivable has changed by -$4.14 M (-1.57%)

What is Integra LifeSciences Holdings quarterly accounts receivable?

The current quarterly accounts receivable of IART is $248.30 M

What is the all time high quarterly accounts receivable for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high quarterly accounts receivable is $296.51 M

What is Integra LifeSciences Holdings quarterly accounts receivable year-on-year change?

Over the past year, IART quarterly accounts receivable has changed by -$7.97 M (-3.11%)